Literature DB >> 8623932

Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.

S Silletti1, S Paku, A Raz.   

Abstract

Autocrine motility factor (AMF) is a tumor-secreted cytokine that acts as a motogen as well as a mitogen via a receptor-mediated signaling pathway(s). Expression of the AMF receptor (AMF-R) in normal cells is regulated by cell contact whereas in transformed cells AMF-R is constitutively expressed irrespective of cell density. Here we have analyzed the regulation of AMF-R expression in a BALB/c angiosarcoma tumor system that allows investigation of cellular characteristics associated with tumor progression. The metastatic cell variant (A31-M) displayed a higher rate of unstimulated motility and responded to tumor-derived AMF locomotory stimulus as compared with the nonmetastatic cell variants (A31-TR and A31-TU) and, although a similar level of receptor expression was detected in cellular extracts from subconfluent cultures of these sublines, surface localization differed and cell contact down-regulated AMF-R expression in the normal but not the transformed cell counterparts. AMF promoted marked rearrangement of focal adhesion plaque proteins in the AMF migration-responsive cells exclusively. Reorganization of vinculin after AMF stimulation was paralleled by morphological redistribution of tyrosine-phosphorylated proteins and the tyrosine kinase pp125FAK in the migration-responsive cells; however, we did not observe a concomitant change in the pp125FAK phosphorylation state or the general level of cellular tyrosine phosphorylation in response to treatment, suggesting that the induction of cellular migration by AMF is independent of tyrosine phosphorylation events at the focal contacts and may therefore represent a novel pathway of cytokine-induced migration regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623932      PMCID: PMC1861574     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Regulation of cell movement: the motogenic cytokines.

Authors:  M Stoker; E Gherardi
Journal:  Biochim Biophys Acta       Date:  1991-04-16

Review 2.  Cell migration in the embryo and adult organism.

Authors:  C A Erickson
Journal:  Curr Opin Cell Biol       Date:  1990-02       Impact factor: 8.382

3.  Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen.

Authors:  I R Nabi; A Raz
Journal:  Int J Cancer       Date:  1987-09-15       Impact factor: 7.396

4.  Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.

Authors:  E C Kohn; L A Liotta; E Schiffmann
Journal:  Biochem Biophys Res Commun       Date:  1990-01-30       Impact factor: 3.575

5.  Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.

Authors:  T Otto; W Birchmeier; U Schmidt; A Hinke; J Schipper; H Rübben; A Raz
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

6.  Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.

Authors:  S Nakamori; H Watanabe; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; A Raz
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

Review 7.  Autocrine motility factor and its receptor: role in cell locomotion and metastasis.

Authors:  I R Nabi; H Watanabe; A Raz
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

8.  Expression of chicken vinculin complements the adhesion-defective phenotype of a mutant mouse F9 embryonal carcinoma cell.

Authors:  M Samuels; R M Ezzell; T J Cardozo; D R Critchley; J L Coll; E D Adamson
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

9.  Autocrine motility factor receptor is a marker for a distinct membranous tubular organelle.

Authors:  N Benlimame; D Simard; I R Nabi
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

10.  Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions.

Authors:  J D Hildebrand; M D Schaller; J T Parsons
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  6 in total

1.  Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.

Authors:  J Timár; S Tóth; J Tóvári; S Paku; A Raz
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 2.  The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer.

Authors:  Xuankun Chen; Li Jiang; Zhesheng Zhou; Bo Yang; Qiaojun He; Chengliang Zhu; Ji Cao
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

3.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

4.  Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum.

Authors:  N Benlimame; P U Le; I R Nabi
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

5.  PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironment.

Authors:  Melanie J Voss; Bernd Niggemann; Kurt S Zänker; Frank Entschladen
Journal:  Cell Commun Signal       Date:  2010-07-13       Impact factor: 5.712

6.  Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.

Authors:  Liliana D Kojic; Sam M Wiseman; Fariba Ghaidi; Bharat Joshi; Hinyu Nedev; H Uri Saragovi; Ivan R Nabi
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.